Federal Health Survey Shows Higher PFAS Chemical Levels in Veterans Ages Twenty to Thirty-Nine

On September 15, 2026, researchers published a cross-sectional study in Environmental Health Perspectives. A Brown- and Harvard-affiliated research team examined serum PFAS concentrations among U.S. veterans and nonveterans. The team utilized data from eight National Health and Nutrition Examination Survey cycles from 2003 through 2018. The central finding showed that veterans ages 20 to 39 had higher adjusted concentrations of several PFAS than same-age nonveterans.

The study arrives as federal agencies continue to address chemical exposure among service members. The analysis included adults aged 20 and older with measured serum PFAS concentrations and self-reported military service. Veterans represented approximately 11 percent of the total participants in the dataset. This participation corresponds to a weighted veteran population estimate of 22,826,063 people.

This new research provides a broad population-level comparison rather than a service-specific exposure assessment. The data came from 2003 through 2018 cycles of the national survey. This means the analysis describes historical serum measurements rather than a newly collected clinical sample. The study examined associations between veteran status and chemical concentrations, not proof that military service caused the differences.

Context and Clinical Implications

This update matters because it clarifies how environmental risks may impact younger military personnel. The researchers evaluated the National Academies of Sciences, Engineering, and Medicine summed seven-PFAS measure. The National Academies clinical-monitoring threshold used in the study was a summed PFAS concentration of at least 20 nanograms per milliliter. This 20 ng/mL threshold serves as a clinical follow-up benchmark rather than a firm diagnosis.

Understanding these clinical benchmarks is vital for those pursuing healthy aging and long term resilience. Proactive monitoring is a core part of comprehensive military health. I remember waking up after a poor night of sleep and realizing my training recovery was taking much longer than it used to. I realized that readiness requires a dedicated approach to sleep and hormonal health, which completely shifted how I view long term capability.

Monitoring environmental exposure requires that exact same objective and practical mindset. The study found age and race modified the statistical associations, showing there is no single uniform veteran effect. Female veterans actually had a 37 percent lower prevalence of summed PFAS concentrations at or above 20 ng/mL than female nonveterans. Furthermore, the association was null among males in the sex-stratified analysis for the wider population.

Navigating post-service health requires separating established medical facts from general anxiety. When managing healthy aging, veterans must focus on actionable data over hypothetical fears. The 20 ng/mL benchmark provides clinicians with a standardized tool for identifying who needs closer observation. It replaces guesswork with a clear metric for future health tracking.

Breaking Down the Study Data

The researchers provided a detailed look at individual chemical compounds across different age groups. The analysis evaluated PFOA and PFOS alongside PFHxS. They also measured PFDA and PFNA concentrations while evaluating the NASEM summed measure. Among adults ages 20 to 39, veterans showed significantly higher adjusted concentrations than similarly aged nonveterans.

In this younger bracket, veterans had 13 percent higher PFOA and 19 percent higher PFOS levels. Younger veterans also demonstrated 24 percent higher PFHxS and 17 percent higher NASEM summed PFAS concentrations. Medical Daily reported these central findings to highlight the differences in chemical concentrations among the younger demographic. The study authors noted that these age-specific differences were statistically meaningful.

The reported 95 percent confidence intervals were 3 to 24 percent for PFOA and 9 to 30 percent for PFOS. For PFHxS, the interval was 9 to 42 percent. The summed PFAS measure showed a confidence interval of 8 to 27 percent. The study authors said the stronger association among younger veterans was consistent with PFAS toxicokinetics.

They suggested younger participants might be closer in time to their military-service-related exposures. When measuring against the clinical threshold, the prevalence gap was clear for younger service members. Veterans ages 20 to 39 had an 18 percent higher prevalence of summed PFAS concentrations at or above 20 ng/mL than nonveterans of the same age. The reported prevalence ratio was 1.18, with a 95 percent confidence interval of 1.04 to 1.33.

The researchers also calculated unadjusted weighted estimates for the broader participant sample. These estimates indicated that 58 percent of veterans overall had summed PFAS concentrations at or above 20 ng/mL. In contrast, 36 percent of nonveterans met or exceeded that same concentration threshold. Overall, veterans actually had lower PFAS concentrations than nonveterans after adjustment.

Despite these distinct numbers, the cross-sectional study has significant limits regarding individual health conclusions. The survey did not capture military branch or specific occupation. It also lacked data on deployment location and time since service. Therefore, researchers could not link specific duties to higher concentrations.

A blood test can document serum concentrations, but it does not establish where the exposure originated. It cannot prove whether the exposure occurred during military service, before enlistment, or through consumer products. The findings were not uniform by sex or age or race. This variation argues against treating younger veterans as a single biologically identical group.

The researchers emphasized that elevated concentrations do not automatically dictate a negative health outcome. A biological measurement simply indicates presence in the bloodstream at a specific moment in time. Because the chemical compounds can remain in the body for years, the cross-sectional data represents cumulative exposure rather than recent contact. This timeline complexity makes individual clinical discussions incredibly important.

Guidance Shifts for Testing and VA Care

These specific findings are changing how younger veterans navigate diagnostic testing and primary care conversations. Christian Hoover is the study lead author and a predoctoral fellow at Brown University School of Public Health. Hoover said young male veterans ages 20 to 39 should speak with a physician about whether PFAS testing is appropriate. He suggested veterans discuss health conditions associated with exposure to determine if additional screening is warranted.

Accessing these diagnostic blood tests currently requires navigating outside the traditional federal healthcare system. PFAS blood testing is not currently available at VA medical centers, according to the VA position described by Medical Daily. The Department of Veterans Affairs does not provide or cover the cost of PFAS blood tests, according to Military Times. The VA is reportedly reevaluating its testing protocols in light of this newer federal research.

A December 2025 notice confirmed that veterans seeking testing could use private laboratories outside the VA system. Because VA facilities do not offer the test, veterans should discuss testing goals with a clinician before paying out of pocket. You should ask your VA primary care team or Environmental Health Coordinator what referral options currently exist. You should also ask how the result will be interpreted and whether it would actually change your medical follow-up.

The Defense Department operates under strict testing mandates that exclude many military personnel. The Defense Department is required by law to offer PFAS blood testing to active-duty and civilian DoD firefighters. However, the 2020 testing mandate does not include retired military firefighters, other active-duty personnel, or dependents. This uneven access means many veterans must seek guidance from veteran lifestyle and healthcare resources and private clinicians.

If you plan to request a private test, documenting your specific service history is crucial. Veterans should document potentially relevant exposure details before speaking with a medical provider. Important details include your duty station, military specialty, and your approximate service dates. You should also note your contact route, the protective equipment used, and possible contaminated water sources.

When consulting a private laboratory, veterans should ask specific questions about the testing methodology. A veteran considering testing should ask the clinician which exact PFAS panel is being used. You should verify whether it reports the NASEM seven-PFAS sum and if the laboratory methods are appropriate for clinical decision-making. This careful approach aligns with the core principles detailed in About BattleVet.

Finally, testing should never replace standard medical observation. A result at or above 20 ng/mL is a reason for clinician-guided follow-up, not a medical diagnosis. It does not prove that military service was the exposure source or that the chemical caused current symptoms. Veterans should continue their ordinary age-based and risk-based preventive care regardless of whether they pursue private testing.

The Future of Veteran Health Monitoring

The study conclusion noted that its findings could inform Veterans Health Administration policy on testing and follow-up. People at or above the NASEM threshold are recommended to receive additional health screening. The recent NHANES analysis provides important population-level context for younger service members navigating their health. As federal agencies continue to address toxic exposures, how will the VA adapt its testing policies to better serve the younger veteran population?

Sources

1. Young Veterans Had Higher Forever Chemical Levels Than ...
2. Study finds ‘forever chemicals' levels higher in younger vets than general population
3. Serum PFAS Concentrations Among US Veterans, NHANES 2003 ...
4. Military Exposure Toolkit - Veteran Cancer Network
5. militarytimes.com